Evidence map›Paper›PMID 22553926›Full record

ArticleDNA and cell biology2012

Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors.

Hanna B Kern, Brian F Niemeyer, Janet K Parrish, Carol A Kerr, Nasser K Yaghi, Jason D Prescott, Arthur Gutierrez-Hartmann, Paul Jedlicka

Open access · greenAbstract read
In one paragraph

Article in DNA and cell biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. MicroRNAs targeting EGFR signalling pathway in colorectal cancer.Journal of cancer research and clinical oncology · 2013
    Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hanna B KernDepartment of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Brian F Niemeyer
Janet K Parrish
Carol A Kerr
Nasser K Yaghi
Jason D Prescott
Arthur Gutierrez-Hartmann
Paul Jedlicka
University of Colorado Anschutz Medical Campus · US

Funding

Ets transcription factors in intestinal biologyK08DK074557 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI JEDLICKA, PAUL · 2006 to 2010
$729k
NIDDK NIH HHS DK074557-04S1NIDDK NIH HHS K08 DK74557
6 · The paper itself

Abstract

MicroRNAs (miRs) are important regulators of gene expression in normal physiology and disease, and are widely misexpressed in cancer. A number of studies have identified miR-21 as an important promoter of oncogenesis. However, as is true of most miRs, the mechanisms behind the aberrant expression of miR-21 in cancer are poorly understood. Herein, we examine the regulation of miR-21 expression in colorectal cancer (CRC) cells by the oncogenic epidermal growth factor (EGF)/Ras pathway and by Ets transcription factors, modulators of epithelial oncogenesis that are frequently misexpressed in CRC. We show that EGF/Ras efficiently induces the miR-21 primary transcript, but this does not rapidly and simply translate into higher mature miR-21 levels. Rather, induction of mature miR-21 by constitutive activation of this pathway is slow, is associated with only minimal activation of mitogen-activated protein kinase, and may involve stimulation of post-transcriptional processing by mechanisms other than Dicer stabilization. We further identify Ets transcription factors as modifiers of miR-21 expression in CRC. The effects of Ets factors on miR-21 expression are cell context-dependent, and appear to involve both direct and indirect mechanisms. The Ets factor Pea3 emerges from our studies as a consistent repressor of miR-21 transcription. Overall, our studies identify a complex relationship between oncogenic pathways and steady-state miR-21 levels in CRC, and highlight the need for greater understanding of the control of miR expression in cancer and other disease states.

Indexed as

Gene Expression Regulation, NeoplasticSignal TransductionCell Line, TumorColorectal NeoplasmsEpidermal Growth FactorHumansMicroRNAsOncogene Protein p21(ras)Proto-Oncogene Proteins c-etsTranscription, GeneticEpidermal Growth FactorMicroRNAsMIRN21 microRNA, humanOncogene Protein p21(ras)Proto-Oncogene Proteins c-ets

Identifiers

PMID22553926
PMCPMC3405454
OpenAlexW2033798431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.